Kantola T, Ilmakunnas M, Koivusalo A M, et al. Bridging therapies and liver transplantation in acute liver failure, 10 years of MARS experience from Finland[J]. Scand J Surg, 2011, 100(1): 8-13. [2]Canbay A, Tacke F, Hadem J, et al. Acute liver failure: a life-threatening disease[J]. Dtsch Arztebl Int, 2011, 108(42): 714-720. [3]Mayo M J, Parkes J, Adams-Huet B, et al. Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assay[J]. Hepatology, 2008, 48(5): 1549-1557. [4]Biggins S W, Kim W R, Terrault N A, et al. Evidence-based incorporation of serum sodium concentration into MELD[J]. Gastroenterology, 2006, 130(6): 1652-1660. [5]Kim W R, Biggins S W, Kremers W K, et al. Hyponatremia and mortality among patients on the liver-transplant waiting list[J]. N Engl J Med, 2008, 359(10): 1018-1026. [6]Barber K, Madden S, Allen J, et al. Elective liver transplant list mortality: development of a United Kingdom end-stage liver disease score[J]. Transplantation, 2011, 92(4): 469-476. [7]中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南(2012年版)[J]. 中华临床感染病杂志, 2012, 5(6): 321-327. [8]Bernal W, Auzinger G, Dhawan A, et al. Acute liver failure[J]. Lancet, 2010, 376(9736): 190-201. [9]Pugh R N, Murray-Lyon I M, Dawson J L, et al. Transection of the oesophagus for bleeding oesophageal varices[J]. Br J Surg, 1973, 60(8): 646-649. [10]Zaman M B, Hoti E, Qasim A, et al. MELD score as a prognostic model for listing acute liver failure patients for liver transplantation [J]. Transplant Proc, 2006, 38(7): 2097-2098. [11]Garg H, Kumar A, Garg V, et al. Clinical profile and predictors of mortality in patients of acute-on-chronic liver failure [J]. Dig Liver Dis, 2012, 44(2): 166-171. [12]Hsu C Y, Lin H C, Huang Y H, et al. Comparison of the model for end-stage liver disease (MELD), MELD-Na and MELDNa for outcome prediction in patients with acute decompensated hepatitis [J]. Dig Liver Dis, 2010, 42(2): 137-142. [13]Kim W R, Biggins S W, Kremers W K, et al. Hyponatremia and mortality among patients on the liver-transplant waiting list [J]. N Engl J Med, 2008, 359(10): 1018-1026. [14]Guy J, Somsouk M, Shiboski S, et al. New model for end stage liver disease improves prognostic capability after transjugular intrahepatic portosystemic shunt[J]. Clin Gastroenterol Hepatol, 2009, 7(11): 1236-1240. [15]金坤, 李磊, 李宜, 等. MELD 相关评分系统对肝衰竭患者生存情况的评估价值[J]. 安徽医学, 2012, 33(11): 1439-1441. [16]Zhao P, Wang C, Liu W, et al. Causes and outcomes of acute liver failure in China [J]. PLoS One, 2013, 8(11): e80991. [17]Witkowski J A, Parish L C. The great imitator: malignant syphilis with hepatitis[J]. Clin Dermatol, 2002, 20(2): 156-163. [18]Zhang X Q, Jiang L, You J P, et al. Efficacy of short-term dexamethasone therapy in acute-on-chronic pre-liver failure[J]. Hepatol Res, 2011, 41(1): 46-53.
[2]
林容,李羲,陈海,等.类鼻疽病早期诊断依据的探讨[J].第三军医大学学报,2009,31(23):2390. LIN Rong,LI Xi,CHEN Hai,et al.Early diagnostic indices for melioidosis: report of 49 cases[J].J Third Mil Med Univ,2009,31(18):2390. [2]周亮,程迪祥,刘岭,等.基于西方人群循证数据的脑卒中发病风险的系统分析[J].第三军医大学学报,2014,36(08):825. Zhou Liang,Cheng Dixiang,Liu Ling,et al.Integrated assessment model of stroke risk by logistic regression： a study based on evidence-based data of Western population[J].J Third Mil Med Univ,2014,36(18):825.
